|
1
|
Villanueva A, Minguez B, Forner A, Reig M
and Llovet JM: Hepatocellular carcinoma: Novel molecular approaches
for diagnosis, prognosis, and therapy. Annu Rev Med. 61:317–328.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers WC: Neoplasms of the liverTextbook
of Surgery: The Biological Basis of Modern Surgical Practice.
Sabiston DC Jr: 1. 15th. W.B. Saunders Co.; Philadelphia: pp.
1069–1072. 1999
|
|
4
|
Bruix J and Sherman MAmerican Association
for the Study of Liver Diseases: Management of hepatocellular
carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
European Association For The Study Of The
Liver; European Organisation For Research And Treatment Of Cancer,
. EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lencioni R, Chen XP, Dagher L and Venook
AP: Treatment of intermediate/advanced hepatocellular carcinoma in
the clinic: How can outcomes be improved? Oncologist. 15 (Suppl
4):S42–S52. 2010. View Article : Google Scholar
|
|
7
|
Yamashita T and Kaneko S: Treatment
strategies for hepatocellular carcinoma in Japan. Hepatol Res.
43:44–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Llovet JM, Brú C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ikai I, Kudo M, Arii S, et al: Report of
the 18th follow-up survey of primary liver cancer in
Japan. Hepatol Res. 40:1043–1059. 2010. View Article : Google Scholar
|
|
10
|
Cucchetti A, Ercolani G, Vivarelli M, et
al: Is portal hypertension a contraindication to hepatic resection?
Ann Surg. 250:922–928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mazzaferro V: Results of liver
transplantation: With or without Milan criteria? Liver Transpl. 13
(11 Suppl 2):S44–S47. –2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mazzaferro V, Bhoori S, Sposito C, et al:
Milan criteria in liver transplantation for hepatocellular
carcinoma: An evidence-based analysis of 15 years of experience.
Liver Transpl. 17 (Suppl 2):S44–S57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishikawa H, Kimura T, Kita R and Osaki Y:
Radiofrequency ablation for hepatocellular carcinoma. Int J
Hyperthermia. 29:558–568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lammer J, Malagari K, Vogl T, et al: Role:
PRECISION V InvestigatorsProspective randomized study of
doxorubicin-eluting-bead embolization in the treatment of
hepatocellular carcinoma: Results of the PRECISION V study.
Cardiovasc Intervent Radiol. 33:41–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nicolini D, Svegliati-Baroni G, Candelari
R, et al: Doxorubicin-eluting bead vs conventional transcatheter
arterial chemoembolization for hepatocellular carcinoma before
liver transplantation. World J Gastroenterol. 19:5622–5632. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng K, Yan J, Li X, et al: A randomized
controlled trial of radiofrequency ablation and surgical resection
in the treatment of small hepatocellular carcinoma. J Hepatol.
57:794–802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Orlando A, Leandro G, Olivo M, et al:
Radiofrequency thermal ablation vs. percutaneous ethanol injection
for small hepatocellular carcinoma in cirrhosis: Meta-analysis of
randomized controlled trials. Am J Gastroenterol. 104:514–524.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cho YK, Kim JK, Kim MY, et al: Systematic
review of randomized trials for hepatocellular carcinoma treated
with percutaneous ablation therapies. Hepatology. 49:453–459. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen A, Zhang H, Tang C, et al: Systematic
review of radiofrequency ablation versus percutaneous ethanol
injection for small hepatocellular carcinoma up to 3 cm. J
Gastroenterol Hepatol. 28:793–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takayasu K, Arii S, Kudo M, et al:
Superselective transarterial chemoembolization for hepatocellular
carcinoma. Validation of treatment algorithm proposed by Japanese
guidelines. J Hepatol. 56:886–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takayasu K: Chemoembolization for
unresectable hepatocellular carcinoma in Japan. Oncology. 78 (Suppl
1):S135–S141. 2010. View Article : Google Scholar
|
|
23
|
Cholongitas E, Papatheodoridis GV, Vangeli
M, Terreni N, Patch D and Burroughs AK: Systematic review: The
model for end-stage liver disease - should it replace Child-Pugh's
classification for assessing prognosis in cirrhosis? Aliment
Pharmacol Ther. 22:1079–1089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bieze M, Klümpen HJ, Verheij J, et al:
Diagnostic accuracy of (18) F-methylcholine positron emission
tomography/computed tomography for intra- and extrahepatic
hepatocellular carcinoma. Hepatology. 59:996–1006. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tenley N, Corn DJ, Yuan L and Lee Z: The
effect of fasting on PET imaging of hepatocellular carcinoma. J
Cancer Ther. 4:561–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu NC, Chaudhari V, Raman SS, et al: CT
and MRI improve detection of hepatocellular carcinoma, compared
with ultrasound alone, in patients with cirrhosis. Clin
Gastroenterol Hepatol. 9:161–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li JJ, Zheng JS, Cui SC, et al: C-arm
Lipiodol CT in transcatheter arterial chemoembolization for small
hepatocellular carcinoma. World J Gastroenterol. 21:3035–3040.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tognolini A, Louie JD, Hwang GL, et al:
Utility of C-arm CT in patients with hepatocellular carcinoma
undergoing transhepatic arterial chemoembolization. J Vasc Interv
Radiol. 21:339–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim MJ, Kim YS, Cho YH, et al: Use of
(18)F-FDG PET to predict tumor progression and survival in patients
with intermediate hepatocellular carcinoma treated by transarterial
chemoembolization. Korean J Intern Med. 30:308–315. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho Y, Lee DH, Lee YB, et al: Does 18F-FDG
positron emission tomography-computed tomography have a role in
initial staging of hepatocellular carcinoma? PLoS One.
9:e105679–2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng J, Li J, Cui X, Ye H and Ye L:
Comparison of diagnostic sensitivity of C-arm CT, DSA and CT in
detecting small HCC. Hepatogastroenterology. 60:1509–1512.
2013.PubMed/NCBI
|
|
32
|
Bartolozzi C, Lencioni R, Caramella D,
Palla A, Bassi AM and Di Candio G: Small hepatocellular carcinoma.
Detection with US, CT, MR imaging, DSA, and Lipiodal-CT. Acta
Radio. 37:69–74. 1996. View Article : Google Scholar
|
|
33
|
Peng ZW, Zhang YJ, Chen MS, et al:
Radiofrequency ablation with or without transcatheter arterial
chemoembolization in the treatment of hepatocellular carcinoma: A
prospective randomized trial. J Clin Oncol. 31:426–432. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang HJ, Lee JH, Lee DH, et al: Small
single-nodule hepatocellular carcinoma: Comparison of transarterial
chemoembolization, radiofrequency ablation, and hepatic resection
by using inverse probability weighting. Radiology. 271:909–918.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scheuermann U, Kaths JM, Heise M, et al:
Comparison of resection and transarterial chemoembolisation in the
treatment of advanced intrahepatic cholangiocarcinoma - a
single-center experience. Eur J Surg Oncol. 39:593–600. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liao M, Huang J, Zhang T and Wu H:
Transarterial chemoembolization in combination with local therapies
for hepatocellular carcinoma: A meta-analysis. PLoS One.
8:e684532013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salhab M and Canelo R: An overview of
evidence-based management of hepatocellular carcinoma: A
meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin ZZ, Shau WY, Hsu C, et al:
Radiofrequency ablation is superior to ethanol injection in
early-stage hepatocellular carcinoma irrespective of tumor size.
PLoS One. 8:e802762013. View Article : Google Scholar : PubMed/NCBI
|
